Stock listing
A3DL7E Stock Price, News, Filings & Events — Therapeuticsmd, Inc.
Selected listing: A3DL7E · LS · EUR · DE
This page tracks Therapeuticsmd, Inc.'s A3DL7E:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3DL7E:LS. A3DL7E:LS is the stock-level entry point for investors researching Therapeuticsmd, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. TherapeuticsMD, Inc. (Ticker: TXMD) is a public company based in the United States, focusing on women's health. With a market capitalization of approximately $23.8 million, the company is engaged in developing and commercializing innovative products for healthcare needs.
- Ticker
- A3DL7E:LS
- Asset type
- Stock
- Market cap
- $25.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Therapeuticsmd, Inc. A3DL7E:LS stock context
This page tracks Therapeuticsmd, Inc.'s A3DL7E:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3DL7E:LS. A3DL7E:LS is the stock-level entry point for investors researching Therapeuticsmd, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. TherapeuticsMD, Inc. (Ticker: TXMD) is a public company based in the United States, focusing on women's health. With a market capitalization of approximately $23.8 million, the company is engaged in developing and commercializing innovative products for healthcare needs.
Latest news from Therapeuticsmd, Inc.
TherapeuticsMD Announces Second Quarter 2026 Financial Results
August 11, 2026
TherapeuticsMD Announces First Quarter 2026 Financial Results
May 12, 2026
TherapeuticsMD : Amendment to Annual Report (Form 10-K/A)
April 1, 2026
TherapeuticsMD Announces Full Year 2025 Financial Results
March 30, 2026
TherapeuticsMD Announces Third Quarter 2025 Financial Results
November 12, 2025
Therapeuticsmd, Inc. earnings calls
TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call
August 15, 2022 · Replay with transcript and chapters
TherapeuticsMD, Inc. (TXMD) Q1 2022 Earnings Call
May 16, 2022 · Replay with transcript and chapters
TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Call
March 10, 2022 · Replay with transcript and chapters
TherapeuticsMD, Inc. (TXMD) Q3 2021 Earnings Call
November 11, 2021 · Replay with transcript and chapters
TherapeuticsMD, Inc. (TXMD) Q2 2021 Earnings Call
August 4, 2021 · Replay with transcript and chapters
TherapeuticsMD, Inc. (TXMD) Q1 2021 Earnings Call
May 6, 2021 · Replay with transcript and chapters
Research Therapeuticsmd, Inc.
Therapeuticsmd, Inc. investor report
Review AI stock analysis and investor report context for A3DL7E:LS.
Therapeuticsmd, Inc. company profile
View the public company page for Therapeuticsmd, Inc. on 6ix.
Therapeuticsmd, Inc. news
Read company news and market updates connected to Therapeuticsmd, Inc..
Therapeuticsmd, Inc. investor events
Find investor webinars, events, and replay context for Therapeuticsmd, Inc..
Alternate listings
TXMD:NASDAQ
US · USD
Alternate listing for Therapeuticsmd, Inc.; the primary context on this page is A3DL7E:LS.
A3DL7E:LSX
DE · EUR
Alternate listing for Therapeuticsmd, Inc.; the primary context on this page is A3DL7E:LS.
TXMD:BOATS
US · USD
Alternate listing for Therapeuticsmd, Inc.; the primary context on this page is A3DL7E:LS.
29TA:DUS
DE · EUR
Alternate listing for Therapeuticsmd, Inc.; the primary context on this page is A3DL7E:LS.
29TA:FWB
DE · EUR
Alternate listing for Therapeuticsmd, Inc.; the primary context on this page is A3DL7E:LS.
29TA:GETTEX
DE · EUR
Alternate listing for Therapeuticsmd, Inc.; the primary context on this page is A3DL7E:LS.
29TA:MUN
DE · EUR
Alternate listing for Therapeuticsmd, Inc.; the primary context on this page is A3DL7E:LS.
29TA:SWB
DE · EUR
Alternate listing for Therapeuticsmd, Inc.; the primary context on this page is A3DL7E:LS.